Pharmacokinetics and bioequivalence of sunitinib and Sutent® in Chinese healthy subjects: an open-label, randomized, crossover study
Purpose: The purpose of this study was to examine the pharmacokinetics (PK), bioequivalence and safety of generic sunitinib and its original product Sutent® in healthy Chinese subjects through a phase-I clinical trial.Methods: The study selected two groups of 24 healthy Chinese subjects in a 1:1 rat...
Saved in:
Main Authors: | Yanli Wang (Author), Qiaohuan Deng (Author), Zhenyue Gao (Author), Guangwen Liu (Author), Zhengjie Su (Author), Yicheng Zhao (Author), Lixiu Zhang (Author), Haimiao Yang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacokinetics and bioequivalence of Ezetimibe tablet versus Ezetrol®:an open-label, randomized, two-sequence crossover study in healthy Chinese subjects
by: Feifei Sun, et al.
Published: (2023) -
Pharmacokinetics and safety of the two oral cefaclor formulations in healthy chinese subjects in the fasting and postprandial states
by: Xinyao Qu, et al.
Published: (2022) -
Pharmacokinetics, bioavailability, and bioequivalence of lower‐sodium oxybate in healthy participants in two open‐label, randomized, crossover studies
by: Cuiping Chen, et al.
Published: (2021) -
Bioequivalence of HTX-019 (aprepitant IV) and fosaprepitant in healthy subjects: a Phase I, open-label, randomized, two-way crossover evaluation
by: Ottoboni T, et al.
Published: (2018) -
Pharmacokinetic Bioequivalence and Safety Assessment of Two Venlafaxine Hydrochloride Extended-Release Capsules in Healthy Chinese Subjects Under Fed Conditions: A Randomized, Open-Label, Single-Dose, Crossover Study
by: Yingxia He, et al.
Published: (2024)